Keywords Cloud

Research Outputs

Co-authors[TOP 5]

Usage Statistics


  Total Views
 86

  Access Source
    internal: 2
    External: 84
    Domestic: 26
    Abroad: 60

  Annual Views
 77

  Access Source
    internal: 2
    External: 75
    Domestic: 20
    Abroad: 57

  Monthly Views
 13

  Access Source
    internal: 0
    External: 13
    Domestic: 5
    Abroad: 8

Visits

Visits

1. Factors contributing to hospitalization costs for patients with CO.. [585]
2. Internationalization of traditional Chinese medicine: current inte.. [579]
3. Consumers' Perceptions About Pharmaceutical Care Provided by Commu.. [569]
4. Internationalization of Traditional/Complementary Medicine product.. [561]
5. Community pharmacists’ opinions and practice of pharmaceutical ca.. [122]
6. Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolid.. [118]
7. Trends and Development in Enteral Nutrition Application for Ventil.. [115]
8. Research and development of mAb drugs in China: a look from policy.. [113]
9. EFFECT AND COST OF TRADITIONAL CHINESE MEDICINE XIYANPING INJECTIO.. [113]
10. DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY.. [108]
11. DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY.. [108]
12. Advancing the pharmacist’s role in promoting the appropriate and .. [107]
13. Healthcare providers' role regarding the safe and appropriate use .. [99]
14. RATE OF HYPOGLYCEMIC EVENTS IN PATIENTS USING BASAL INSULIN ANALOG.. [95]
15. UTILIZTION OF MONOCLONAL ANTIBODY IN CHINA: A STUDY FROM NATOINAL .. [93]
16. MEDICAL COSTS OF HYPOGLYCEMIA IN TYPE 1 AND TYPE 2 DIABETES PATIEN.. [90]
17. SOCIAL UNDERSTANDING OF LUNG FUNCTION EXAMINATION IN CHINA: A CROS.. [87]
18. A RETROSPECTIVE STUDY OF THE HOSPITAL USE OF ENTERAL NUTRITION IN .. [85]
19. Opportunities and Challenges of Multinational Pharmaceutical Enter.. [83]
20. Phytochemicals, pharmacology, clinical application, patents, and p.. [61]
21. Community pharmacists’ understanding, attitudes, practice and per.. [57]
22. Good manufacturing practice (GMP) regulation of herbal medicine in.. [57]
23. An analysis of chemical ingredients network of Chinese herbal form.. [50]
24. Development of Monoclonal Antibodies in China: Overview and Prospe.. [46]
25. Community pharmacists' perceptions about pharmaceutical service of.. [45]
26. 執業藥師藍皮書- 中國執業藥師發展報告2015 [45]
27. Barriers to pharmacists adopting professional responsibilities tha.. [45]
28. Large expert-curated database for benchmarking document similarity.. [45]
29. Community Pharmacists' Perceptions about Pharmaceutical Care of Tr.. [42]
30. Cost-consequence analysis of salvianolate injection for the treatm.. [40]
31. Efficacy and safety of traditional Chinese medicines for non-alcoh.. [40]
32. Valuation of Pharmaceutical Patents: A Comprehensive Analytical Fr.. [38]
33. Prevalence and trend of major transfusion-transmissible infections.. [38]
34. Doctor’s presenteeism and its relationship with anxiety and depre.. [38]
35. Obstacles and opportunities in Chinese pharmaceutical innovation [37]
36. Marketing Strategy: The Chinese Pharmaceutical Market: Dynamics an.. [35]
37. Development of a strategic model for integrating complementary med.. [31]
38. Community pharmacist's responsibilities with regards to traditiona.. [30]
39. Naturally Occurring Diterpenoid Dimers: Source, Biosynthesis, Chem.. [29]
40. Community pharmacists’ perceptions about pharmaceutical care of O.. [28]
41. Consumers' Perceptions About Pharmaceutical Care Provided by Commu.. [27]
42. Community pharmacist's responsibilities with regards to traditiona.. [27]
43. Benefits and challenges of electronic health record system on stak.. [27]
44. Key stakeholder perspectives on the barriers and solutions to phar.. [26]
45. Clinical and Economic Evaluation of Salvianolate Injection for Cor.. [22]
46. An evaluation of randomized controlled trials on nutraceuticals co.. [22]
47. Factors Contributing to Patients' Preferences for Primary Health C.. [21]
48. Integrating traditional Chinese medicines into professional commun.. [21]
49. Community pharmacist's perceptions and practice behaviors related .. [20]
50. Involving systems thinking and implementation science in pharmacis.. [20]
51. Factors affecting community pharmacist’s knowledge about chronic .. [19]
52. Development and Validation of a Logic Model for Utilization of Nut.. [19]
53. The prevalence, perceptions and behaviors associated with traditio.. [17]
54. Promoting community pharmacy practice for chronic obstructive pulm.. [17]
55. Exploratory study on development challenges of maternal and child .. [17]
56. Evaluation of the association between presenteeism and perceived a.. [16]
57. The Use of Microblog “Weibo” by Chinese Patent Medicine Companie.. [16]
58. The provision of care provided by the pharmacy workforce in relati.. [15]
59. Safety of medication use during pregnancy in mainland China: Based.. [15]
60. Medication use during pregnancy in mainland china: A cross-section.. [15]